Australia's Challenger rejects Daiichi Life unit takeover bid, but open to further talks

By Reuters News

- Australia's Challenger CGF.AX said on Monday an indicative proposal from a unit of Japan's Daiichi Life 8750.T to buy more than 79% of shares in the Australian investment manager is "not at a level it could recommend to shareholders".

  • Earlier this month, TAL Daiichi Life Australia made an indicative proposal of A$11.80 per share, valuing Challenger at A$7.94 billion ($5.58 billion).

  • Challenger said on Monday its board intends to engage with TAL Daiichi Life Australia Pty to see whether a proposal can be reached "that the board could recommend."

  • "There is no certainty that the proposal will result in a binding offer or that any transaction will eventuate," the Australian firm said in its statement.

  • Shares of Challenger were down as much as 1% to A$11.80 per share by 2313 GMT.

  • Japanese insurer Daiichi Life, the parent firm of TAL Daiichi Life Australia, did not immediately respond to a Reuters request for comment.

($1 = 1.4241 Australian dollars)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk